PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsgastrointestinal diseases
MeSH D005767 - gastrointestinal diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D004066:Digestive system diseases
1 Company
1 Drug
$
Success rate
D005767: 
Gastrointestinal diseases
32 Companies
12 Drugs
$
Success rate
D000079562:Rumination syndrome
0 Companies
0 Drugs
Success rate
D004935:Esophageal diseases
80 Companies
15 Drugs
$
Success rate
D005759:Gastroenteritis
55 Companies
7 Drugs
$
Success rate
D005770:Gastrointestinal neoplasms
28 Companies
6 Drugs
$
Success rate
D006471:Gastrointestinal hemorrhage
3 Companies
1 Drug
$
Success rate
D007410:Intestinal diseases
0 Companies
0 Drugs
Success rate
D013272:Stomach diseases
2 Companies
3 Drugs
$
Success rate
D014385:Gastrointestinal tuberculosis
0 Companies
0 Drugs
Success rate
D014782:Visceral prolapse
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
PadagisHydrocortisone, Bacitracin, Neomycin, Polymyxin b Bacitracin-neomycin-polymyxin W/ Hydrocortisone  1982-01-01   
Dexamethasone, Neomycin, Polymyxin b Neomycin Polymyxin B Sulfates Dexamethasone  1989-07-31   
SandozDexamethasone, Neomycin, Polymyxin b Maxitrol  1984-05-22   
Hydrocortisone, Neomycin, Polymyxin b Neomycin Polymyxin B Sulfates Hydrocortisone  1983-08-25   
NovartisDexamethasone, Neomycin, Polymyxin b Dexacidin  1984-10-29   
Bausch Health CompaniesDexamethasone, Neomycin, Polymyxin b Dexasporin  1995-09-13   
Dexamethasone, Neomycin, Polymyxin b Neomycin Polymyxin B Sulfates Dexamethasone  1994-07-25   
Hydrocortisone, Neomycin, Polymyxin b Neomycin Polymyxin B Sulfates Hydrocortisone  1995-12-29   
Hydrocortisone, Bacitracin, Neomycin, Polymyxin b Neomycin Polymyxin B Sulfates, Bacitracin Hydrocortisone  1995-10-30   
Hydrocortisone, Neomycin, Polymyxin b Oticair  1996-08-28   
Merck & CoHydrocortisone, Neomycin, Polymyxin b Otobione  1982-01-01   
Hydrocortisone, Polymyxin b Otobiotic  1982-01-01   
AllerganHydrocortisone, Neomycin, Polymyxin b Otocort  1982-01-01   
Forest LaboratoriesHydrocortisone, Polymyxin b Pyocidin  1982-01-01   
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
78%
7/9
Phase 2
27%
7/26
Phase 3
17%
2/12
Approved: 2Overall Success rate: 3%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
GSK
Neomycin,
Benzocaine,
Doconexent,
Pariet,
Antacid,
Alviompan
Novartis
Dexamethasone,
Mycophenolate sodium,
Fendrix
Bausch Health Companies
Dexamethasone,
Hydrocortisone,
Trimethoprim,
Neomycin,
Polymyxin b,
Lactobacillus acidophilus,
Arm1,
Lactobacillus,
Arm2
Merck & Co
Hydrocortisone,
Hydrocortisone probutate,
Hydrocortisone butyrate,
Neomycin,
Polymyxin b,
RUZASVIR,
UPRIFOSBUVIR,
Arm1,
Arm2
Allergan
Hydrocortisone,
Hydrocortisone butyrate,
Hydrocortisone probutate,
Prednisolone,
Prednisolone tebutate
Pfizer
Polymyxin b
Forest Laboratories
Hydrocortisone,
Hydrocortisone butyrate,
Hydrocortisone probutate
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use